Latest Medicine stories from Life.
Replimune is set to make a third attempt for FDA approval of its drug, while Pfizer has recently secured a deal in China, highlighting ongoing developments in the pharmaceutical sector.
A recent study by researchers at University Medical Center Göttingen and the Max Planck Institute sheds light on the regulation of protein synthesis in mitochondria, with potential implications for understanding mitochondrial diseases.
Questions remain about the implications of Trump's Most Favored Nation deals with pharmaceutical companies, as scrutiny increases.
As the ASCO conference approaches, attention is drawn to pancreatic cancer developments, alongside significant biotech advancements including GSK's hepatitis B drug.
The FDA has postponed its decision on AstraZeneca's experimental breast cancer pill after an advisory panel voted against its approval, signaling further review is needed.
Eli Lilly has announced encouraging results from a recent clinical trial of its gene-editing therapy, indicating a significant reduction in cholesterol levels among participants.
Researchers at Osaka Metropolitan University have introduced a novel light-driven method that efficiently concentrates bacteria, potentially improving diagnostic capabilities.
Recent discussions reveal a split between EU and US advisers regarding AstraZeneca's breast cancer drug, amid notable developments in other biotech areas.
Biogen and Denali's experimental treatment for Parkinson's disease has not achieved its trial objectives, while Merck's lung cancer therapy appears to offer potential benefits.
Genentech is seeking research to bolster its position against potential pharmaceutical reforms in Washington, aiming to influence policy discussions.
Recent findings reveal significant issues with the release of drugs from nanoparticle carriers, raising concerns for the future of precision medicine.
The Department of Justice has ordered an executive from Elevance to testify regarding allegations of fraudulent billing related to Medicare Advantage.
Eli Lilly's investigational drug, known as 'triple-G', has demonstrated significant effects on blood sugar and weight in a late-stage diabetes trial.
In a move to address leadership vacancies, Kennedy has appointed Stephanie Haridopolos, a family medicine physician and senior HHS adviser, as interim surgeon general.
Researchers have identified a crucial enzyme in bioluminescent fungi, potentially leading to more effective medical tools that utilize light.
Goat’s rue, a wild plant known for its beauty, has played a significant role in the development of metformin, a key medication for diabetes and obesity, without the adverse effects.
At the STAT Breakthrough Summit West, 23andMe announced a partnership with HealthEx, enabling users to connect their DNA data with their medical records.
In a notable decision, Virginia's governor has vetoed legislation that sought to establish an advisory panel aimed at lowering prescription drug prices, impacting potential savings for residents.
Researchers at Florida State University have made significant strides in drug discovery by synthesizing new molecules from bacteria sourced from a Pacific Ocean sea sponge, which could aid in developing treatments for rare cancers.
A recent analysis indicates that most Canadian medical societies do not have adequate conflict-of-interest policies, with many existing policies being fragmented and limited in scope.